Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways. - Zhou L; Yang T; Zhang S; Liu D; Feng C; Ni J; Shi Q; Liu Y; Meng Y; Zhu Y; Tang H; Wang J; et al. (Journal of molecular medicine (Berlin, Germany), 2025)